<?xml version="1.0" encoding="UTF-8"?>
<p id="Par37">Clinical research has been seriously threatened by COVID-19 epidemics. New recruitments in ongoing clinical trials have been temporarily suspended. Investigators can consult with sponsors in order to reassess follow-up visit schedules and amend protocol requirements to facilitate online visits. When accorded with the Sponsor and local Pharmacy, investigational product home-delivery service and a digital medicine service can be activated to administer scheduled questionnaires and monitor domiciliary drug self-administration [
 <xref ref-type="bibr" rid="CR9">9</xref>].
</p>
